bf/NASDAQ:VYGR_icon.jpeg

COM:VOYAGERTHERAPEUTICS

Voyager Therapeutics

  • Stock

USD

Last Close

5.43

22/11 21:00

Market Cap

439.50M

Beta: -

Volume Today

359.89K

Avg: -

  • name

    Voyager Therapeutics, Inc.
  • homepage url

    www.voyagertherapeutics.com
  • country

    USUnited States
  • employee count

    162
  • sector

    Healthcare
  • industry

    Biotechnology
  • revenue

    250.01M

Description

Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyotrophic lateral sclerosis; VY-HTT...Show More

peer of

investor of

competitor of